WASHINGTON— Drugmaker Merck has asked U.S. regulators to authorize its promising antiviral pill against COVID-19, mounting the signifier for a determination wrong weeks.
If cleared by the Food and Drug Administration, it would beryllium the archetypal pill shown to dainty COVID-19, adding a new, easy-to-use limb to the world's arsenal against the pandemic.
The FDA volition scrutinize institution information connected the drug’s information and effectiveness earlier rendering a decision.
All COVID-19 drugs present authorized by the FDA necessitate an IV oregon injection.
This communicative is breaking and volition beryllium updated.